NYSE:ZBHMedical Equipment
Zimmer Biomet Holdings (ZBH) Could Be 2% Undervalued As Q2 Beat Lifts The Story
Zimmer Biomet Holdings (ZBH) is in focus after second quarter results topped Wall Street expectations, with management pointing to hip market share gains, expanding technology and robotics adoption, and fresh products like the Z1 hip stem and OrthoGrid navigation.
See our latest analysis for Zimmer Biomet Holdings.
The recent second quarter beat and ongoing buyback program have coincided with building momentum in Zimmer Biomet Holdings’ share price, with a 90 day share price return of 20.25%...